These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
601 related articles for article (PubMed ID: 19335126)
1. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome. Smith ER; McClain CD; Heeney M; Scott RM Neurosurg Focus; 2009 Apr; 26(4):E10. PubMed ID: 19335126 [TBL] [Abstract][Full Text] [Related]
2. Treatment of Moyamoya disease in the adult population with pial synangiosis. Lin N; Aronson JP; Manjila S; Smith ER; Scott RM J Neurosurg; 2014 Mar; 120(3):612-7. PubMed ID: 24405066 [TBL] [Abstract][Full Text] [Related]
3. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization. Jea A; Smith ER; Robertson R; Scott RM Pediatrics; 2005 Nov; 116(5):e694-701. PubMed ID: 16263984 [TBL] [Abstract][Full Text] [Related]
4. Pial synangiosis for moyamoya syndrome in children with sickle cell anemia: a comprehensive review of reported cases. Kennedy BC; McDowell MM; Yang PH; Wilson CM; Li S; Hankinson TC; Feldstein NA; Anderson RC Neurosurg Focus; 2014 Jan; 36(1):E12. PubMed ID: 24380478 [TBL] [Abstract][Full Text] [Related]
5. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization. Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626 [TBL] [Abstract][Full Text] [Related]
6. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis. Scott RM; Smith JL; Robertson RL; Madsen JR; Soriano SG; Rockoff MA J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):142-9. PubMed ID: 14758941 [TBL] [Abstract][Full Text] [Related]
7. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis. Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765 [TBL] [Abstract][Full Text] [Related]
8. Down syndrome and moyamoya: clinical presentation and surgical management. See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890 [TBL] [Abstract][Full Text] [Related]
9. Pial synangiosis in patients with moyamoya younger than 2 years of age. Jackson EM; Lin N; Manjila S; Scott RM; Smith ER J Neurosurg Pediatr; 2014 Apr; 13(4):420-5. PubMed ID: 24527861 [TBL] [Abstract][Full Text] [Related]
10. Surgical Revascularization for Children with Moyamoya Disease: A New Modification to the Pial Synangiosis. Chen C; Wang H; Hou B; Luo L; Guo Y World Neurosurg; 2018 Feb; 110():e203-e211. PubMed ID: 29102749 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome. Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127 [TBL] [Abstract][Full Text] [Related]
12. Moyamoya syndrome and PHACE syndrome: clinical and radiographic characterization of the intracranial arteriopathy and response to surgical revascularization. Jernigan S; Storey A; Hammer C; Riordan C; Orbach DB; Scott RM; Smith E J Neurosurg Pediatr; 2019 Apr; 23(4):493-497. PubMed ID: 30717056 [TBL] [Abstract][Full Text] [Related]
13. [Pial synangiosis for moyamoya disease. The Bordeaux experience]. Jecko V; Penchet G; Champeaux C Neurochirurgie; 2016 Aug; 62(4):190-6. PubMed ID: 27113323 [TBL] [Abstract][Full Text] [Related]
14. Progression of disease in unilateral moyamoya syndrome. Smith ER; Scott RM Neurosurg Focus; 2008; 24(2):E17. PubMed ID: 18275294 [TBL] [Abstract][Full Text] [Related]
15. Surgical Revascularization for Pediatric Patients with Sickle Cell Disease and Moyamoya Disease in the Prevention of Ischemic Strokes: A Single-Center Case Series and a Systematic Review. Aguilar-Salinas P; Hayward K; Santos R; Agarwal V; Sauvageau E; Hanel RA; Aldana PR World Neurosurg; 2019 Mar; 123():435-442.e8. PubMed ID: 30496928 [TBL] [Abstract][Full Text] [Related]
16. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article. Pandey P; Steinberg GK J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138 [TBL] [Abstract][Full Text] [Related]
17. The importance of encephalo-myo-synangiosis in surgical revascularization strategies for moyamoya disease in children and adults. Imai H; Miyawaki S; Ono H; Nakatomi H; Yoshimoto Y; Saito N World Neurosurg; 2015 May; 83(5):691-9. PubMed ID: 25655688 [TBL] [Abstract][Full Text] [Related]
18. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease. Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886 [TBL] [Abstract][Full Text] [Related]
19. Relative contributions of the middle meningeal artery and superficial temporal artery in revascularization surgery for moyamoya syndrome in children: the results of superselective angiography. King JA; Armstrong D; Vachhrajani S; Dirks PB J Neurosurg Pediatr; 2010 Feb; 5(2):184-9. PubMed ID: 20121368 [TBL] [Abstract][Full Text] [Related]
20. Preoperative transdural collateral vessels in moyamoya as radiographic biomarkers of disease. Storey A; Michael Scott R; Robertson R; Smith E J Neurosurg Pediatr; 2017 Mar; 19(3):289-295. PubMed ID: 27935469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]